Repositori URV

Identificador: imarina:9262254

Handle: https://hdl.handle.net/20.500.11797/imarina9262254

Autors:
Pons-Rodriguez, AnnaMarzo-Castillejo, MerceCruz-Esteve, InesGalindo-Ortego, GiselaJose Hernandez-Leal, MariaRue, Montserrat

Resum:
Breast cancer is the leading cause of death in the world among women. The Spanish National Health System (SNHS) introduced population-based breast cancer screening in 2006. As in most European programs, risk is identified on the basis of age and a mammogram is offered every two years to women aged 50–69 years. Scientific evidence is moving toward personalized screening, based on individual risk. This article presents the clinical trials that will evaluate the efficacy of personalized screening and some studies carried out in our environment on the effect of informing women of the benefits and adverse effects of screening or the acceptability and feasibility of offering personalized screening, in the Shared Decision Making context. The Preventive Activities and Health Promotion Program can help transform screening in our SNHS.